Pharmacoeconomics of amifostine in ovarian cancer.

Calhoun, E A

Pharmacoeconomics of amifostine in ovarian cancer. [electronic resource] - Seminars in oncology Apr 1999 - 102-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0093-7754


Amifostine--economics
Antineoplastic Agents--adverse effects
Canada
Cost-Benefit Analysis
Cytoprotection
Female
Humans
Models, Economic
Ovarian Neoplasms--economics
Protective Agents--economics
Quality-Adjusted Life Years
United States